| Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia U Nekanti, S Dastidar, P Venugopal, S Totey, M Ta International journal of biological sciences 6 (5), 499, 2010 | 229 | 2010 |
| Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications U Nekanti, L Mohanty, P Venugopal, S Balasubramanian, S Totey, M Ta Stem cell research 5 (3), 244-254, 2010 | 182 | 2010 |
| Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study P Swamynathan, P Venugopal, S Kannan, C Thej, U Kolkundar, ... Stem cell research & therapy 5, 1-17, 2014 | 142 | 2014 |
| Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow S Balasubramanian, C Thej, P Venugopal, N Priya, Z Zakaria, ... Cell biology international 37 (5), 507-515, 2013 | 84 | 2013 |
| Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions P Venugopal, S Balasubramanian, AS Majumdar, M Ta Stem Cells and Cloning: Advances and Applications, 39-50, 2011 | 74 | 2011 |
| Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells S Balasubramanian, P Venugopal, S Sundarraj, Z Zakaria, AS Majumdar, ... Cytotherapy 14 (1), 26-33, 2012 | 66 | 2012 |
| Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes CE Chong, P Venugopal, PH Stokes, YK Lee, PJ Brautigan, DTO Yeung, ... Leukemia 32 (1), 194-202, 2018 | 59 | 2018 |
| Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy CN Hahn, P Venugopal, HS Scott, DK Hiwase Immunological reviews 263 (1), 257-278, 2015 | 57 | 2015 |
| Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics Z Hu, HS Scott, G Qin, G Zheng, X Chu, L Xie, DL Adelson, BE Oftedal, ... Scientific reports 5 (1), 10940, 2015 | 53 | 2015 |
| GATA2 deficiency syndrome: a decade of discovery CC Homan, P Venugopal, P Arts, NH Shahrin, S Feurstein, L Rawlings, ... Human Mutation 42 (11), 1399-1421, 2021 | 46 | 2021 |
| Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies C Saygin, G Roloff, CN Hahn, R Chhetri, S Gill, H Elmariah, C Talati, ... Blood Advances 7 (4), 549-554, 2023 | 34 | 2023 |
| Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient P Venugopal, S Moore, DM Lawrence, AJ George, RD Hannan, SCE Bray, ... Haematologica 102 (12), e506, 2017 | 30 | 2017 |
| A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature J Kazenwadel, P Venugopal, A Oszmiana, J Toubia, L Arriola-Martinez, ... Nature 614 (7947), 343-348, 2023 | 25 | 2023 |
| Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41 CC Homan, MW Drazer, K Yu, DM Lawrence, J Feng, L Arriola-Martinez, ... Blood Advances 7 (20), 6092-6107, 2023 | 22 | 2023 |
| Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia CN Hahn, PJ Brautigan, CE Chong, A Janssan, P Venugopal, Y Lee, ... Leukemia 29 (8), 1795-1797, 2015 | 16 | 2015 |
| Somatic mutational landscape of hereditary hematopoietic malignancies associated with germline variants in RUNX1, GATA2 and DDX41 AL Brown, C Homan, MW Drazer, K Yu, D Lawrence, J Feng, ... Blood 140 (Supplement 1), 4030-4033, 2022 | 4 | 2022 |
| Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss P Venugopal, L Gagliardi, C Forsyth, J Feng, K Phillips, M Babic, ... BMC Medical Genetics 21, 1-5, 2020 | 4 | 2020 |
| Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features V Carruthers, M Nicola, P Venugopal, CN Hahn, HS Scott, T Revesz Journal of paediatrics and child health 53 (10), 1018-1020, 2017 | 3 | 2017 |
| ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy HS Scott, J Zerella, C Homan, P Arts, S Lin, SJ Spinelli, M Babic, ... Blood 142, LBA-6, 2023 | 2 | 2023 |
| An integrative genomic approach to examine mutations and biological pathways associated with hematological malignancy development in DDX41 mutated families P Venugopal, JJC Cheah, L Eshraghi, NH Shahrin, C Homan, J Feng, ... Blood 134, 2686, 2019 | 2 | 2019 |
Hamish S ScottCenter of Cancer BiologyVerified email at sa.gov.au
